Bioinformatics Paradigms in Drug Discovery and Drug Development

Abstract

Despite breakthroughs in medical sciences, drug development remains a time-consuming, expensive, challenging, and inefficient process with a high failure rate for novel therapeutic discoveries. Bioinformatics analysis can speed up drug target identification, drug candidate screening, and refining, but it can also help characterise adverse effects and anticipate drug resistance. Integrated genomics, proteomics, and bioinformatics have resulted in potent new tactics for resolving numerous biochemical problems and establishing new methodologies that result in new biomedical products. As a result, a new research trend emerged to demonstrate the mechanism of therapeutic action, forecast drug resistance, and uncover biomarkers for various disorders. The development of new medications is a complicated procedure. There are two basic approaches to drug design: ligand-based drug design and structure-based drug design. The study of protein structure and function was essential for drug development. Current techniques based on combinatorial approaches such as proteomics, genomics, bioinformatics, molecular docking, and mass spectrometry were applied. This article provides an overview of the combinatorial techniques of proteomics, genomics, and bioinformatics that aid in understanding the drug-creation process.

Bioinformatics Applications in Chronic Diseases: A Comprehensive Review of Genomic, Transcriptomics, Proteomic, Metabolomics, and Machine Learning Approaches

“…To predict binding affinity and therapeutic efficacy, computational methods like molecular docking, virtual screening, and quantitative structure-activity relationship modeling are used. Furthermore, bioinformatics tools facilitate the modification of previously authorized pharmaceuticals for new circumstances, offering a means of repurposing drugs and accelerating novel treatments while maximizing resources (Gupta et al, 2023).…”

Bioinformatics Analysis Identifies Potential Hub Genes, Therapeutic Agents, and Crucial Pathways in the Pathogenesis of Refsum's Disease

“…In comparison to the time-and moneyconsuming process of developing novel pharmacological remedies, repurposing an existing medication to address a disease other than its original purpose may be a more efficient and affordable option (Moosavinasab et al, 2016). Text mining of biomedical literature is a helpful method for creating hypotheses since it can unveil novel connections among genes and disorders (Mosca et al, 2009;Sharma et al, 2023). Together with biological awareness and advanced analytical techniques, text mining can be used to obtain new information on the potential for repurposing existing medications (Butcher et al, 2004).…”

Integrated Bioinformatics and Machine Learning Algorithms of Identify Novel Diagnostic Biomarkers and Chinese Medicine Targets in Chronic Atrophic Gastritis

“…In transitional medicine, bioinformatics algorithms enable the creation of large-scale data repositories, as well as the identi cation and evaluation of new drug targets and biomarkers [17]. Overall, bioinformatics holds immense potential in candidate drug analysis, drug target identi cation, characterization of side effects, and prediction of drug resistance [18,19].…”